NH-Amundi Announces the Listing of HANARO Bio Korea Active ETF
NH-Amundi Asset Management announced on the 26th the launch of the 'HANARO Bio Korea Active ETF', focusing on the domestic bio healthcare sector. This ETF aims to invest in major domestic bio healthcare companies such as Samsung Biologics, Celltrion, and Alteogen, with a goal of surpassing the iSelect K-Bio Healthcare index. NH-Amundi has highlighted the promising growth potential of the bio industry, particularly anticipating increased profits from new drug developments beginning in the latter half of 2025.
The ETF adopts an active management strategy to achieve returns exceeding the benchmark index, engaging in proactive investment activities. NH-Amundi perceives the current market conditions as an opportune time for investment, noting ample opportunities to achieve excess returns in the growing bio healthcare market.
Related News
NH-Amundi to List 'HANARO Bio Korea Active ETF' - Financial NewsNH-Amundi Asset Management announced that it will list the HANARO Bio Korea Active ETF on the 26th. The HANARO Bio Korea Active ETF is a product that focuses on investing in domestic biotechnology and healthcare companies. It aims to achieve superior performance compared to the benchmark index through active management. The benchmark index for this product is the iSelect K-..
NH-Amundi Asset Management, 'HANARO Bio Korea Active ETF' Newly Listed - Korea Economic DailyNH-Amundi Asset Management, HANARO Bio Korea Active ETF newly listed, focused investment in domestic bio healthcare companies, including Samsung Biologics, Celltrion, and biosimilars.
NH-Amundi Launches HANARO Bio Korea Active ETF - Money TodayNH-Amundi Asset Management launched the 'HANARO Bio Korea Active' ETF on the 26th. The 'HANARO Bio Korea Active' ETF is a product that invests intensively in domestic bio healthcare companies. It seeks to outperform its benchmark index through active management. The benchmark index is the iSelect K-Bio Healthcare Index. The constituent stocks in the benchmark index include Samsung Biologics, Celltrion, Alteogen, etc.
NH Amundi Asset Management, Lists HANARO Bio Korea Active ETF - E-DailyNH-Amundi Asset Management announced that it will list the HANARO Bio Korea Active Exchange-Traded Fund (ETF) on the 26th. The HANARO Bio Korea Active ETF is a domestic bio